DTx Pharma Study Discovers Multiple Therapeutic Candidates for CMT1A
DTx Pharma discovered new molecules that could be treatment candidates for Charcot-Marie-Tooth disease type 1A, hitting the second milestone of its study
0 Comments
DTx Pharma Study Discovers Multiple Therapeutic Candidates for CMT1A
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed